期刊文献+

重型β地中海贫血患者肝脏胰腺和心脏铁负荷磁共振成像T2*的多中心研究 被引量:8

A multiple-center clinical study on quantitative T2* magnetic resonance imaging of iron deposition of liver,pancreas and heart of beta-thalassemia major patients
原文传递
导出
摘要 目的探讨使用磁共振成像T2*(MRI T2*)方法检测重型β地中海贫血(重型β地贫)患者肝脏、胰腺和心脏铁过载状况,并评估其有效性。方法总结2010年5月至2010年12月中国广东及广西省共7所医院的153例重型β地贫患者的临床资料,对其肝脏、胰腺、心脏MRI T2*与年龄、血清铁蛋白作相关性分析,并按肝脏不同铁沉积等级比较患者心脏和(或)胰腺铁沉积的情况。结果心脏铁沉积重度37例,轻度21例,正常95例。肝脏、胰腺和心脏MRI T2*值与血清铁蛋白水平有相关性,但与年龄无相关性,血清铁蛋白水平也与年龄无关。肝脏与胰腺T2*值(r=0.529,P=0.000)、肝脏与心脏的T2*值(r=0.369,P=0.000)以及胰腺与心脏T2*值(r=0.715,P=0.000)有相关性。随着肝脏铁沉积等级的增加,患者同时合并心和胰腺的比例也随之增大(χ2=20.78,P=0.000)。结论肝脏、胰腺、心脏三器官间的MRI T2*值有相关性。随着肝脏铁沉积等级增加,患者合并心脏、胰腺铁沉积的比例逐渐增高。 ObjectiveTo study the T2* magnetic resonance imaging for evaluation of iron deposition of liver,pancre-as and heart in β- thalassemia major(β-TM)patients and the relationship of the serum ferritin with iron overload.MethodsMeasurement of hepatic,pancreatic and cardiac MRI T2* was performed in 153 patients with β-TM fromMay 1,2010 to December 31,2010. The demographics and serum ferritin(SF)were collected. The rate of the ironoverload in liver,pancreas and heart was analyzed. The rates of combined pancreatic and cardiac iron overload in differ-ent hepatic iron overload groups were compared.ResultsAccording to MRI T2*,there was serious hepatic iron over-load in 85 cases,moderate in 39,mild in 21,no iron overload in 8. Similarly,there was pancreatic iron overload in134,no iron overload in 19. In terms of cardiac iron overload,there was serious cardiac iron overload in 37 cases,mildin 21,no iron overload in 95. No correlation was found between hepatic,pancreatic and cardiac MRI T2* and age orSF,but hepatic MRI T2* correlated with pancreatic and cardiac MRI T2*(P = 0.000,r = 0.529,r = 0.369),and pan-creatic MRI T2* correlated with cardiac MRI T2* well(P = 0.000,r = 0.715). As grade of hepatic iron over-load increases,the patients demonstrated higher rate ofcombination of pancreatic and cardiac iron overload si-multaneously( χ2= 20.78, P = 0.000).ConclusionThere are correlations among hepatic T2*,pancreatic T2* and myocardial T2*. The patients withβ-TM show higher rate of combined pancreatic and cardiaciron overload simultaneously with the increasing degree of hepatic iron overload.
出处 《中国实用儿科杂志》 CSCD 北大核心 2014年第11期845-848,共4页 Chinese Journal of Practical Pediatrics
基金 深圳市科技计划项目(重点)(No.201001019)
关键词 重型Β地中海贫血 铁沉积 肝脏T2* 胰腺T2* 心脏T2* β-thalassemia major iron overload hepatic T2* pancreatic T2* cardial T2*
  • 相关文献

参考文献4

二级参考文献27

  • 1王爱萍,刘超,王晓东,段宇,蒋琳.铁储备与2型糖尿病临床相关性的研究[J].南京医科大学学报(自然科学版),2006,26(1):17-20. 被引量:12
  • 2Li CG,Li CF,Li Q,Li M.Thalassemia incidence and treatmentin China with special reference to Shenzhen City and Guangdongprovince[J].Hemoglobin,2009,33(5):296-303.
  • 3Cohen AR,Galanello R,Pennell DJ,Cunningham MJ,VichinskyE.Thalassemia[J].Hematology Am Soc Hematol Educ Program,2004:14-34.
  • 4Beutler E,Hoffbrand AV,Cook JD.Iron deficiency and overload[J].Hematology Am Soc Hematol Educ Program,2003:40-61.
  • 5Au WY,Lam WW,Chu WW,Yuen HL,Ling AS,Li RC,et al.A cross-sectional magnetic resonance imaging assessment of organspecific hemosiderosis in 180 thalassemia major patients in HongKong[J].Haematologica,2008,93(5):784-786.
  • 6Borgna-Pignatti C,Rugolotto S,De Stefano P,Piga A,Di Grego-rio F,Gamberini MR,et al.Survival and disease complications inthalassemia major[J].Ann N Y Acad Sci.1998,30(850):227-231.
  • 7Gabutti V,Piga A.Results of long-term iron-chelating therapy[J].Acta Haematol,1996,95(1):26-36.
  • 8Borgna-Pignatti C,Rugolotto S,De Stefano P,Zhao H,Cappelli-ni MD,Del Vecchio GC,et al.Survival and complications in pa-tients with thalassemia major treated with transfusion and deferox-amine[J].Haematologica,2004,89(10):1187-1193.
  • 9Modell B,Khan M,Darlison M,Westwood MA,Ingram D,Pen-nell DJ.Improved survival of thalassaemia major in the UK and re-lation to T2*cardiovascular magnetic resonance[J].J CardiovascMagn Reson,2008,10:42.
  • 10Pennell DJ.Berdoukas V,Karagiorga M,Ladis V,Piga A,Aes-sopos A,et al.Randomized controlled trial of deferiprone or def-eroxamine in beta-thalassemia major patients with asymptomaticmyocardial siderosis[J].Blood,2006,107(9):3738-3744.

共引文献27

同被引文献58

  • 1王爱萍,刘超,王晓东,段宇,蒋琳.铁储备与2型糖尿病临床相关性的研究[J].南京医科大学学报(自然科学版),2006,26(1):17-20. 被引量:12
  • 2邓燕艺,张华,马晓红,谢树英,卢桂森.116例地中海贫血血糖检测及临床意义[J].中国小儿血液与肿瘤杂志,2007,12(2):74-75. 被引量:1
  • 3Musallam K M, Cappellini M D, Taher A T.Iron overload in 13-thalassemia intermedia: An emerging concern[J].Curr Opin Hematol, 2013, 20 ( 3 ) : 187-192.
  • 4Pennell D J, Porter J B, Piga A, et al.Sustained improvements in myocardial T2* over 2 years in severely iron-overloaded patients with beta thalassemia major treated with deferasirox or deferoxamine[J].Am J Hematol, 2015, 90 ( 2 ) : 91-96.
  • 5Musallam K M, Cappellini M D, Taher A T.Evaluation of the 5mg/g liver iron concentration threshold and its association with morbidity in patients with 13-thalassemia intermedia[J].Blood Cells Mol Dis, 2013, 51 ( 1 ) : 35-38.
  • 6Saito H, Hayashi H.Transformation rate between ferritin and hemosiderin assayed by serum ferritin kinetics in patients with normal iron stores and iron overload[J].Nagoya J Med Sci, 2015, 77 ( 4 ) : 571-583.
  • 7Kontoghiorghe C N, Kolnagou A, Kontoghiorghes G J.Phytochelators intended for clinical use in iron overload, other diseases of iron imbalance and free radical pathology[J].Molecules, 2015, 20 ( 11 ) : 20841-20872.
  • 8Darwish S F, EI-Bakly W M, EI-Naga R N, et al.Antifibrotic mechanism of deferoxamine in concanavalin A induced-liver fibrosis: Impact on interferon therapy[J].Biochem Pharmacol, 2015, 98 ( 1 ) : 231-242.
  • 9Choi C W, Lee J, Lee H J.Deferoxamine improves alveolar and pulmonary vascular development by upregulating hypoxia- inducible factor-1 ot in a rat model of bronchopulmonary dysplasia[J].J Korean Med Sci, 2015, 30 ( 9 ) : 1295-1301.
  • 10黄永兰,刘莎,夏婷,郝文革,梁薇,孙新.重型β-地中海贫血患儿生长发育异常及其与铁超负荷的关系[J].中国当代儿科杂志,2008,10(5):603-606. 被引量:16

引证文献8

二级引证文献44

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部